These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 10735925)
1. Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients-a double-blind placebo-controlled study. Miwa H; Hirai S; Nagahara A; Murai T; Nishira T; Kikuchi S; Takei Y; Watanabe S; Sato N Aliment Pharmacol Ther; 2000 Mar; 14(3):317-24. PubMed ID: 10735925 [TBL] [Abstract][Full Text] [Related]
2. Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Lamouliatte H; Samoyeau R; De Mascarel A; Megraud F Aliment Pharmacol Ther; 1999 Nov; 13(11):1523-30. PubMed ID: 10571611 [TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia. Froehlich F; Gonvers JJ; Wietlisbach V; Burnand B; Hildebrand P; Schneider C; Saraga E; Beglinger C; Vader JP; Am J Gastroenterol; 2001 Aug; 96(8):2329-36. PubMed ID: 11513170 [TBL] [Abstract][Full Text] [Related]
4. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. Blum AL; Talley NJ; O'Moráin C; van Zanten SV; Labenz J; Stolte M; Louw JA; Stubberöd A; Theodórs A; Sundin M; Bolling-Sternevald E; Junghard O N Engl J Med; 1998 Dec; 339(26):1875-81. PubMed ID: 9862942 [TBL] [Abstract][Full Text] [Related]
5. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. Talley NJ; Janssens J; Lauritsen K; Rácz I; Bolling-Sternevald E BMJ; 1999 Mar; 318(7187):833-7. PubMed ID: 10092259 [TBL] [Abstract][Full Text] [Related]
6. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study. Kyzekova J; Mour J Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396 [TBL] [Abstract][Full Text] [Related]
7. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. Talley NJ; Vakil N; Ballard ED; Fennerty MB N Engl J Med; 1999 Oct; 341(15):1106-11. PubMed ID: 10511608 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication. Tursi A; Cammarota G; Montalto M; Papa A; Cuoco L; Veneto GM; Cannizzaro O; Fedeli G; Gasbarrini G Panminerva Med; 1996 Sep; 38(3):145-9. PubMed ID: 9009677 [TBL] [Abstract][Full Text] [Related]
9. Two-week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing. Louw JA; van Rensburg CJ; Hanslo D; Grundlings HD; Girdwood AH; Marks IN Aliment Pharmacol Ther; 1998 Jun; 12(6):545-50. PubMed ID: 9678814 [TBL] [Abstract][Full Text] [Related]
11. Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up. Koelz HR; Arnold R; Stolte M; Fischer M; Blum AL; Gut; 2003 Jan; 52(1):40-6. PubMed ID: 12477757 [TBL] [Abstract][Full Text] [Related]
12. Omeprazole-amoxycillin versus omeprazole-amoxycillin-clarithromycin in the eradication of Helicobacter pylori. Delchier JC; Elamine I; Goldfain D; Chaussade S; Barthelemy P; Idström JP Aliment Pharmacol Ther; 1996 Jun; 10(3):263-8. PubMed ID: 8791948 [TBL] [Abstract][Full Text] [Related]
13. Omeprazole-based antimicrobial therapies: results in 198 Helicobacter pylori-positive patients. Deltenre M; Jonas C; van Gossum M; Buset M; Otero J; De Koster E Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S39-44. PubMed ID: 8574734 [TBL] [Abstract][Full Text] [Related]
14. Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection. Tursi A; Cammarota G; Montalto M; Papa A; Veneto G; Cuoco L; Trua F; Branca G; Fedeli G; Gasbarrini G Aliment Pharmacol Ther; 1996 Jun; 10(3):285-8. PubMed ID: 8791952 [TBL] [Abstract][Full Text] [Related]
15. Triple therapy with clarithromycin, omeprazole, and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa. Wong BC; Chang FY; Abid S; Abbas Z; Lin BR; Van Rensburg C; Chen PC; Schneider H; Simjee AE; Hamid SS; Seebaran A; Zhang J; Destefano M; Lam SK Aliment Pharmacol Ther; 2000 Nov; 14(11):1529-35. PubMed ID: 11069326 [TBL] [Abstract][Full Text] [Related]
16. Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection. Spinzi GC; Bierti L; Bortoli A; Colombo E; Fertitta AM; Lanzi GL; Venturelli R; Minoli G Aliment Pharmacol Ther; 1998 May; 12(5):433-8. PubMed ID: 9663722 [TBL] [Abstract][Full Text] [Related]
17. H. pylori and nonulcer dyspepsia: not guilty as charged. Schubert ML Gastroenterology; 1999 Jul; 117(1):270-2. PubMed ID: 10381939 [No Abstract] [Full Text] [Related]
18. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial. Labenz J; Blum AL; Bolten WW; Dragosics B; Rösch W; Stolte M; Koelz HR Gut; 2002 Sep; 51(3):329-35. PubMed ID: 12171952 [TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia. Koskenpato J; Farkkilä M; Sipponen P Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319 [TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori. Laine L; Estrada R; Trujillo M; Fukanaga K; Neil G Aliment Pharmacol Ther; 1996 Dec; 10(6):1029-33. PubMed ID: 8971306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]